Adrenal disease

KCNJ5 Somatic Mutations Are Associated With Better Long-term Outcomes in Patients With Unilateral Primary Aldosteronism

J Clin Endocrinol MetabPublished Retrospective cohort study

Main finding · MACCEs and mortalityResult — go to the resultHazard ratio 0.46

Authors' conclusion

Patients with uPA harboring KCNJ5 somatic mutations had a lower risk of long-term MACCEs and mortality following adrenalectomy. These patients were more likely to achieve complete clinical success, which contributed to improved outcomes. However, the benefits were influenced by factors such as baseline potassium levels, hypertension duration, BMI, eGFR, and residual hypertension, highlighting the interplay of genetic and clinical factors in determining prognosis.

Study context

Population
Patients with unilateral PA who underwent adrenalectomy 2013–2017, Taiwan Primary Aldosteronism Investigation database, followed until 2020; 46.7% men, mean age 51.3 years
Participants
358 patients
Exposure
KCNJ5 somatic mutation carriers vs non-carriers
  • KCNJ5 mutationn = 188
Outcome
Complete clinical success at 1 year after adrenalectomy; long-term major adverse cardiac and cerebrovascular events (MACCEs) and mortality
Methodological detailslongitudinal, population-based
  • Longitudinal
  • Population-based

Main finding

MACCEs and mortality · long-term

Hazard ratio

0.46

P = 0.044

As reported in the abstract

Observational data: associations, not effects.

Further findings

OutcomeOR for complete clinical successP value
Complete clinical success · 1 year after adrenalectomyHigher likelihood with KCNJ5 mutation1.98P = 0.016

Baseline predictors of KCNJ5 somatic mutations

Younger age, OR (P = .001)
2.44
Lower BMI, OR (P = .005)
2.04
Lower potassium, OR (P < .001)
6.55
Larger tumor size, OR (P = .023)
2.05

Other factors associated with major adverse cardiac and cerebrovascular events (MACCEs) and mortality

Shorter duration of hypertension (lower risk), HR (P = .008)
1.05
Achieved complete clinical success (lower risk), HR (P = .036)
0.49

Original publication

KCNJ5 Somatic Mutations Are Associated With Better Long-term Outcomes in Patients With Unilateral Primary Aldosteronism. J Clin Endocrinol Metab. Published 9 January 2025. doi:10.1210/clinem/dgaf007

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.